Keeping Track: Industry Beefs Up 2020 Review Pipeline With Submissions Galore

The latest drug development news and highlights from our US FDA Performance Tracker.

Keeping Track Feature image

Industry has flooded the US Food and Drug Administration's inbox with a bevy of recent submission announcements – too many to fit into a small introduction. So we'll skip the preamble this week and bring you right to the action:

Clinical-stage biopharma MorphoSys AG's relapsed/refractory diffuse large B cell lymphoma (r/r DLBCL) combination treatment of tafasitamab and Revlimid (lenalidomide)...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers